Ecopetrol
EC
Petroleo Brasileiro SA Petrobras
PBR
D.R. Horton
DHI
Taylor Morrison Home
TMHC
KB Home
KBH
US Stock MarketDetailed Quotes
CASI CASI Pharmaceuticals
- 3.1200
- +0.0500+1.63%
Trading Dec 27 11:03 ET
48.34MMarket Cap-1.40P/E (TTM)
3.1200High2.9100Low15.75KVolume2.9100Open3.0700Pre Close47.71KTurnover0.23%Turnover RatioLossP/E (Static)15.49MShares8.190052wk High3.49P/B21.55MFloat Cap2.050052wk Low--Dividend TTM6.91MShs Float11137.4899Historical High--Div YieldTTM6.84%Amplitude1.4500Historical Low3.0280Avg Price1Lot Size
CASI Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 5.32%-19.97M | 21.44%-21.09M | 88.97%-843K | -69.02%-6.52M | -29.20%-9.48M | 47.03%-4.24M | -3.69%-26.84M | 4.87%-7.64M | 43.48%-3.86M | -14.87%-7.34M |
| Net income from continuing operations | 34.77%-26.26M | -12.32%-40.26M | -258.50%-19.34M | 49.87%-5.02M | -11.11%-7.49M | 38.61%-8.4M | 24.56%-35.84M | 61.53%-5.4M | 40.21%-10.02M | 20.64%-6.74M |
| Operating gains losses | 82.40%-426K | -494.84%-2.42M | ---- | ---- | ---- | ---- | 64.67%-407K | --0 | ---472K | ---- |
| Depreciation and amortization | 54.46%3.74M | 33.44%2.42M | 115.50%890K | 81.71%765K | -28.17%334K | -16.09%433K | -7.35%1.82M | -13.05%413K | -5.39%421K | -9.88%465K |
| Other non cash items | ---- | ---- | ---- | ---- | ---- | ---- | -63.23%6.56M | --0 | --0 | --1.06M |
| Change In working capital | -17.56%-7.82M | -106.65%-6.65M | 999.19%2.7M | -2,363.92%-3.58M | -128.40%-5.74M | 96.22%-42K | 3.01%-3.22M | 472.73%246K | 110.25%158K | -30.71%-2.51M |
| -Change in receivables | 189.43%2.84M | 38.54%-3.17M | 90.58%-413K | -759.03%-2.3M | -345.07%-174K | 76.28%-283K | -53.88%-5.16M | -673.37%-4.39M | 123.68%349K | 109.70%71K |
| -Change in inventory | -130.18%-9.74M | -667.88%-4.23M | -102.78%-365K | -98.97%18K | -330.35%-2.07M | -10.74%-1.81M | -117.29%-551K | 71.70%-180K | 702.76%1.75M | -130.46%-481K |
| -Change in prepaid assets | 150.69%701K | -6.14%-1.38M | -49.87%-1.15M | 44.44%-495K | -241.75%-974K | 93.25%1.23M | -608.15%-1.3M | -405.60%-764K | -122.19%-891K | -630.77%-285K |
| -Change in payables and accrued expense | -175.68%-1.62M | -43.75%2.13M | -17.24%4.58M | 23.75%-790K | -38.55%-2.5M | -23.38%839K | 227.83%3.79M | 540.97%5.54M | -263.15%-1.04M | 33.66%-1.8M |
| -Change in other working capital | ---- | ---- | ---- | 16.67%-10K | -46.15%-19K | -25.00%-15K | ---- | ---- | 0.00%-12K | ---13K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 5.32%-19.97M | 21.44%-21.09M | 88.97%-843K | -69.02%-6.52M | -29.20%-9.48M | 47.03%-4.24M | -3.69%-26.84M | 4.87%-7.64M | 43.48%-3.86M | -14.87%-7.34M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -131.04%-9.67M | 250.59%31.16M | 478.70%17.95M | 666.21%16.45M | 1.64%-961K | 81.04%-2.29M | 0.14%-20.69M | 62.28%-4.74M | 46.33%-2.91M | 69.32%-977K |
| Net PPE purchase and sale | 96.27%-204K | 38.74%-5.47M | 34.30%-3.43M | 81.41%-467K | 411.45%707K | -133.23%-2.29M | -496.06%-8.94M | -360.69%-5.22M | -851.52%-2.51M | -122.55%-227K |
| Net intangibles purchase and sale | ---2.04M | --0 | --0 | --0 | --0 | --0 | 56.67%-6.56M | --0 | 96.74%-305K | 30.62%-750K |
| Net investment purchase and sale | -124.61%-7.43M | --30.2M | --14.94M | --16.92M | ---- | ---- | --0 | --0 | --0 | ---- |
| Net other investing changes | ---- | 223.75%6.44M | ---- | ---- | ---- | ---- | -333.65%-5.2M | 1,429.03%474K | -102.12%-89K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -131.04%-9.67M | 250.59%31.16M | 478.70%17.95M | 666.21%16.45M | 1.64%-961K | 81.04%-2.29M | 0.14%-20.69M | 62.28%-4.74M | 46.33%-2.91M | 69.32%-977K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 72.24%-907K | -111.02%-3.27M | -201.11%-3.27M | 531.75%2M | 1M | -109.62%-3M | -37.14%29.64M | -241.83%-1.09M | -101.13%-463K | 0 |
| Net issuance payments of debt | --0 | --0 | -176.50%-3M | 531.75%2M | --1M | --0 | -167.17%-839K | -238.57%-1.09M | ---463K | --0 |
| Net common stock issuance | 91.49%-278K | -110.05%-3.27M | ---267K | --0 | --0 | -109.23%-3M | -27.94%32.5M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --109K | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net other financing activities | ---738K | ---- | ---- | ---- | ---- | ---- | 28.35%-2.02M | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 72.24%-907K | -111.02%-3.27M | -201.11%-3.27M | 531.75%2M | --1M | -109.62%-3M | -37.14%29.64M | -241.83%-1.09M | -101.13%-463K | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 21.72%47.11M | -32.17%38.7M | -44.96%29.24M | -68.75%18.86M | -57.05%29.26M | -32.17%38.7M | 6.42%57.06M | -28.78%53.13M | 34.46%60.36M | 26.41%68.12M |
| Current changes in cash | -548.96%-30.55M | 138.03%6.8M | 202.80%13.84M | 265.02%11.93M | -13.54%-9.44M | -185.65%-9.53M | -3,364.78%-17.89M | 32.11%-13.47M | -125.17%-7.23M | 8.48%-8.32M |
| Effect of exchange rate changes | -67.71%518K | 442.00%1.6M | 521.57%4.03M | -77,350.00%-1.55M | -271.27%-954K | 217.39%81K | -116.20%-469K | -141.38%-955K | -100.20%-2K | 512.09%557K |
| End cash Position | -63.74%17.08M | 21.72%47.11M | 21.72%47.11M | -44.96%29.24M | -68.75%18.86M | -57.05%29.26M | -32.17%38.7M | -32.17%38.7M | -28.78%53.13M | 34.46%60.36M |
| Free cash flow | 16.82%-22.21M | 36.94%-26.7M | 66.79%-4.27M | -4.55%-6.99M | -7.18%-8.91M | 54.94%-6.53M | 6.35%-42.34M | 16.05%-12.86M | 62.20%-6.69M | -9.82%-8.32M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.